The constellation of the metabolic insulin resistance (diminished strength of insulin signaling along the PI 3-kinase branch of its action) and hyperinsulinemia results in overstimulation of the MAP kinase signaling branch and chronic activation of FTase with a subsequent increases in the amounts of farnesylated Ras. The gene discussed is INS; the disease is hyperinsulinism.